Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase i trial

HIGHLIGHTS

• who: Ching-Yun Hsieh from the Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, have published the Article: Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial, in the Journal: (JOURNAL) of 24/04/2020
• what: The major objective measurement for feasibility was to identify unpredicted harm during the course of combination treatment.
• how: The authors conducted a phase I study to evaluate the feasibility and safety of B cell depletion . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.